Javitt Jonathan C
SEC insider (Form 3/4/5 filer). CIK 0001303782. Chairman and Chief Scientist at NRX Pharmaceuticals, Inc. (NRXP). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2025. Located in WILMINGTON, DE.
Companies Javitt Jonathan C has filed insider reports for
- NRX Pharmaceuticals, Inc. (NRXP): Director, Officer, 10% Owner, Chairman and Chief Scientist
Javitt Jonathan C
CIK: 0001303782
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRXP
NRX Pharmaceuticals, Inc.
DirectorOfficer10% Owner